Norway's OTC Market In 2018: Sales Remain Stable As GSK Consolidates Its Leading Position

Sales of non-prescription medicines in Norway edged up by less than 1% in 2018, as GSK remained the leading player on the market and its Otrivin respiratory line maintained its position as the country's best-selling OTC brand. 

Norway flag
• Source: Shutterstock

Norway’s market for non-prescription medicines remained roughly stable in 2018, according to figures from local pharmaceutical industry association Legemiddelindustrien (LMI) and Farmastat.

Sales of non-prescription products over the 12 months edged up by 0.3% to NOK1.45bn ($170m) at pharmacy purchase prices. Higher...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Europe

More from Geography